European Association of Urology Pocket Guidelines 2019

Description

Introduction We are delighted to present the 2019 edition of the European Association of Urology (EAU) Guidelines, the most comprehensive, continuously updated, guidelines available for urologists and clinicians from related specialties. Produced by a dedicated Guidelines Office, involving approximately 300 international experts and endorsed by more than 67 national societies around the world, the EAU Guidelines are internationally recognised as an excellent, high-quality resource for assisting clinicians in their everyday practice. For the 2019 edition of the EAU Guidelines, we are proud to present a new guideline from the Urolithiasis Panel on the treatment of Bladder Stones. Additionally, numerous guidelines texts and recommendations have been updated including important updates to guideline recommendations on MRI in Prostate cancer screening and, additional guidance on PD1, PD-L1 inhibitors in Muscle-invasive Bladder Cancer. There are also a number of changes to the supporting materials for the 2019 EAU Guidelines, with a brand new mobile app for 2019 and a separate summary version of the Primary Urethral Carcinoma in EAU 2019 Pocket Guidelines. The EAU Guidelines Office have long been aware that the key to the successful implementation of clinical guidelines involves both the identification of impediments to knowledge transfer and the identification of the key interventions for overcoming these barriers. As such, maintaining an effective dissemination strategy is crucial to the continued success of the EAU Guidelines. Much progress has been made in ensuring the international reach of the Guidelines in recent years, with the New Media group being one of the key drivers of this process. Throughout 2018, the Guidelines Office produced a series of infographics - combining images and text to relay complex information - based on popular guidelines recommendations. These infographics have been an enormous success and we will continue to make use of them as a tool for dissemination and knowledge transfer in 2019. Going forward, the EAU Guidelines Office has a number of plans in place for the coming year, and beyond. We are delighted to announce the formation of a new working group to address the EAU Guidelines on Sexual and Reproductive Health which consolidates the work of the former Male Infertility, Male Sexual Dysfunction and Male Hypogonadism Panels. Under the auspices of chairman Prof.Dr. A. Salonia and vice-chair Mr. S. Minhas, the Panel has already begun work on producing a completely revamped guideline for publication in 2020. Additionally, a new ad-hoc panel has been convened to produce a series of systematic reviews and guidelines on the topic of urethral strictures, for 2021 publication. The Panel is chaired by Prof.Dr. N. Lumen and held their inaugural meeting in January 2019. A further goal for the Guidelines Office in 2019 is a commitment to producing a series of interactive care pathways. Clinical pathways are detailed, evidence-based treatment protocols for delivering care to patients with specific disease types and stages. It is anticipated that these pathways will serve as important tool for presenting recommendations, helping patients make informed decisions regarding their treatment and for improving and unifying care quality and reducing costs. The coming year will also see a continued drive to increase patient involvement in Guidelines development. Patient representation on Guidelines panels is steadily growing, with the ultimate aim of ensuring that the EAU Guidelines Office develops an effective framework to meaningfully capture the voices of patients in the development of future guidelines recommendations. Finally, it has to be mentioned that the annual publication of the EAU Guidelines would not be possible without the steadfast support of every user of the Guidelines globally, our EAU membership, our greatly respected Guidelines Panels, Guidelines Associates, the EAU Executive Committee and Management team, the Guidelines Office staff and, last but definitely not least, the National Urological Societies. So, on behalf of the EAU Guidelines Office Board, thank you for your support and inspiration. We hope you find the 2019 update of the EAU Guidelines a pleasure to use!! Non-muscle-invasive (Ta, T1 and CIS) Bladder Cancer Upper Urinary Tract Urothelial Carcinoma Muscle-Invasive and Metastatic Bladder Cancer Primary Urethral Carcinoma Prostate Cancer Renal Cell Carcinoma Testicular Cancer Penile Cancer Management of Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), incl. benign prostatic obstruction (BPO) Erectile dysfunction, Premature Ejaculation, Penile Curvature and Priapism Male Infertility Male Hypogonadism Urological Infections Urinary Incontinence in Adults Neuro-Urology Urolithiasis Bladder Stones Paediatric Urology Urological Trauma Chronic Pelvic Pain Renal Transplantation Thromboprophylaxis in Urological Surgery Abbreviations